Processa Pharmaceuticals, Inc. (PCSA) financial statements (2020 and earlier)

Company profile

Business Address 7380 COCA COLA DRIVE
HANOVER, MD 21076
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6921,7412,8473221
Cash and cash equivalents6921,7412,8473221
Receivables 2263   
Inventory, net of allowances, customer advances and progress billings     222
Inventory     222
Prepaid expense 25841   
Deferred costs     (273)
Disposal group, including discontinued operation    12 
Assets held-for-sale, not part of disposal group    42
Other undisclosed current assets316   48408
Total current assets:1,0072,0202,9523104379
Noncurrent Assets
Property, plant and equipment91726190466
Intangible assets, net (including goodwill), including: 10,438   1,696
Intangible assets, net (excluding goodwill) 10,438    
Other undisclosed intangible assets, net (including goodwill)     1,696
Deposits noncurrent assets 6    
Other noncurrent assets9,867 6   
Other undisclosed noncurrent assets   (19)  
Total noncurrent assets:9,87610,46131 02,163
TOTAL ASSETS:10,88312,4812,98331042,542
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities311416151742416315
Accounts payable7629251166159190
Accrued liabilities2131036413595106
Taxes payable   000
Interest and dividends payable22203644116220
Debt8802302,4491,3821,366236
Due to related parties0 0   
Disposal group, including discontinued operation    300 
Other undisclosed current liabilities   230 288
Total current liabilities:1,1926462,6002,3542,083840
Noncurrent Liabilities
Long-term debt and lease obligation147    360
Long-term debt, excluding current maturities     360
Operating lease, liability147
Liabilities, other than long-term debt1,5322,13410   
Accounts payable and accrued liabilities  10   
Deferred tax liabilities, net2,134    
Deferred income tax liabilities1,532
Other undisclosed noncurrent liabilities     134
Total noncurrent liabilities:1,6792,13410  494
Total liabilities:2,8712,7802,6102,3542,0831,334
Stockholders' equity
Stockholders' equity attributable to parent, including:8,0139,701373(2,351)(1,979)1,208
Preferred stock   000
Common stock144111
Common stock, value, subscriptions 1,800    
Additional paid in capital18,99419,1214,22914,32914,32214,112
Accumulated deficit(10,982)(7,624)(3,859)(15,255)(14,875)(12,905)
Other undisclosed stockholders' equity attributable to parent0(3,600) (1,426)(1,428) 
Total stockholders' equity:8,0139,701373(2,351)(1,979)1,208
TOTAL LIABILITIES AND EQUITY:10,88312,4812,98331042,542

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues  55113200
Revenue, net 575101
Other income  5  
Cost of revenue    (126)(1,810)
Cost of goods and services sold    (126)(113)
Amortization of capitalized value of business acquired asset(1,696)
Other undisclosed gross profit     1,696
Gross profit:  55(12)87
Operating expenses(3,935)(4,525)(1,802)(77)(2,679)(4,247)
Other operating expense, net   (266)(292)(366)
Other undisclosed operating loss  (5)   
Operating loss:(3,935)(4,525)(1,802)(337)(2,983)(4,526)
Nonoperating income
(Investment Income, Nonoperating)
12185 50
Interest and debt expense(37)(161)(59)(241)(236)1,188
Loss from continuing operations before equity method investments, income taxes:(3,961)(4,668)(1,856)(578)(3,214)(3,338)
Other undisclosed income (loss) from continuing operations before income taxes   241231(1,188)
Loss from continuing operations before income taxes:(3,961)(4,668)(1,856)(337)(2,983)(4,526)
Income tax benefit603903  00
Loss from continuing operations:(3,358)(3,765)(1,856)(337)(2,983)(4,526)
Income (loss) from discontinued operations   1(371) 
Loss before gain (loss) on sale of properties:(3,358)(3,765)(1,856)(336)(3,354)(4,526)
Other undisclosed net loss     (0)
Net loss:(3,358)(3,765)(1,856)(336)(3,354)(4,526)
Net income (loss) attributable to noncontrolling interest   43(43)(1,503)
Other undisclosed net income (loss) attributable to parent   (43)431,503
Net loss attributable to parent:(3,358)(3,765)(1,856)(336)(3,354)(4,526)
Other undisclosed net loss available to common stockholders, basic(507)  (43)(43)(1,503)
Net loss available to common stockholders, diluted:(3,865)(3,765)(1,856)(379)(3,397)(6,029)

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(3,358)(3,765)(1,856)(336)(3,354)(4,526)
Comprehensive loss, net of tax, attributable to parent:(3,358)(3,765)(1,856)(336)(3,354)(4,526)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: